6-Polyaminosteroid Squalamine Analogues Display Antibacterial Activity against Resistant Pathogens

Int J Mol Sci. 2023 May 10;24(10):8568. doi: 10.3390/ijms24108568.

Abstract

A series of 6-polyaminosteroid analogues of squalamine were synthesized with moderate to good yields and evaluated for their in vitro antimicrobial properties against both susceptible and resistant Gram-positive (vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus) and Gram-negative (carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa) bacterial strains. Minimum inhibitory concentrations against Gram-positive bacteria ranged from 4 to 16 µg/mL for the most effective compounds, 4k and 4n, and showed an additive or synergistic effect with vancomycin or oxacillin. On the other hand, the derivative 4f, which carries a spermine moiety like that of the natural trodusquemine molecule, was found to be the most active derivative against all the resistant Gram-negative bacteria tested, with an MIC value of 16 µg/mL. Our results suggest that 6-polyaminosteroid analogues of squalamine are interesting candidates for Gram-positive bacterial infection treatments, as well as potent adjuvants to fight Gram-negative bacterial resistance.

Keywords: Acinetobacter baumannii; Enterococcus faecium; Pseudomonas aeruginosa; Staphylococcus aureus; aminosteroid derivatives; antimicrobial activities; polyamine.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Cholestanols
  • Gram-Negative Bacteria
  • Gram-Positive Bacteria
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Vancomycin / pharmacology

Substances

  • Vancomycin
  • squalamine
  • Anti-Bacterial Agents
  • Cholestanols